What You Should Know:
– Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital with participation from new investor Canada Pension Plan Investment Board…
Continue Reading
“Sepsis is more deadly than heart attack and stroke combined — in fact it’s the deadliest, costliest, and arguably most complex condition facing hospitals today.”
Those remarks came from Ajay Shah, CEO of San Francisco-based…
Continue Reading
Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced it scored $84 million in Series C funding led by Norwest Venture Partners with participation from other investors. WHAT THEY DO
Cytovale…
Sepsis kills more than 11 million people worldwide each year and contributes to 20% of all global deaths. The disease is also a leading cause of death in U.S. hospitals, and a septic patient’s…
Continue Reading
